• Product NameLYRM3 Antibody
• Host SpeciesRabbit
• ClonalityPolyclonal
• PurificationAffinity chromatography purified via peptide column
• ApplicationsELISA WB IHC
• Species ReactivityHu Ms Rt
• Immunogen TypePeptide
• Immunogen DescriptionRaised against a 17 amino acid peptide near the carboxy terminus of human LYRM3.
• Target NameLYRM3
• Alternative Names    LYR motif-containing protein 3, NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9, NDUFB9, B22, UQOR22
• Accession No. Q9Y6M9
• UniprotQ9Y6M9
• Gene ID4715;
• Concentration 1mg/ml
• Formulation Supplied in PBS containing 0.02% sodium azide.
• Storage Can be stored at -20˚C, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

LYRM3, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.

• Western blot analysis of LYRM3 in human liver tissue lysate with LYRM3 antibody at (A) 1 and (B) 2 ug/mL.
• Immunohistochemistry of LYRM3 in rat liver tissue with LYRM3 antibody at 5 ug/mL.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting